Aim: To test the efficacy and toxicity of exosomal doxorubicin (exoDOX) compared with free doxorubicin. Materials & methods: The cytotoxic effects of exoDOX were tested in vitro and in nude mice by measuring the tumor volume. The toxic effects were evaluated by measuring the bodyweight and through histopathologic analyses. The biodistribution of DOX was assessed by MS. Results: In vitro and in vivo studies showed that exosomes did not decrease the efficacy of DOX. Surprisingly, exoDOX showed no cardiotoxicity as observed in DOX-treated mice and MS studies confirmed that the accumulation of exoDOX in the heart was reduced by approximately 40%. Conclusion: We demonstrated that exoDOX was less toxic than DOX through its altered biodistribution.

Exosomal doxorubicin reduces the cardiac toxicity of doxorubicin

TOFFOLI, GIUSEPPE;PALAZZOLO, STEFANO;SEMERARO, SABRINA;GAMINI, AMELIA;Canzonieri, Vincenzo;
2015-01-01

Abstract

Aim: To test the efficacy and toxicity of exosomal doxorubicin (exoDOX) compared with free doxorubicin. Materials & methods: The cytotoxic effects of exoDOX were tested in vitro and in nude mice by measuring the tumor volume. The toxic effects were evaluated by measuring the bodyweight and through histopathologic analyses. The biodistribution of DOX was assessed by MS. Results: In vitro and in vivo studies showed that exosomes did not decrease the efficacy of DOX. Surprisingly, exoDOX showed no cardiotoxicity as observed in DOX-treated mice and MS studies confirmed that the accumulation of exoDOX in the heart was reduced by approximately 40%. Conclusion: We demonstrated that exoDOX was less toxic than DOX through its altered biodistribution.
2015
Pubblicato
https://www.futuremedicine.com/doi/10.2217/nnm.15.118
File in questo prodotto:
File Dimensione Formato  
nnm15118_Rizzolio.pdf

Accesso chiuso

Descrizione: articolo
Tipologia: Documento in Versione Editoriale
Licenza: Digital Rights Management non definito
Dimensione 3.06 MB
Formato Adobe PDF
3.06 MB Adobe PDF   Visualizza/Apri   Richiedi una copia
2863568_nnm15118_Rizzolio-PostPrint.pdf

accesso aperto

Descrizione: Post Print VQR3
Tipologia: Bozza finale post-referaggio (post-print)
Licenza: Digital Rights Management non definito
Dimensione 2.03 MB
Formato Adobe PDF
2.03 MB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11368/2863568
Citazioni
  • ???jsp.display-item.citation.pmc??? 38
  • Scopus 116
  • ???jsp.display-item.citation.isi??? 107
social impact